Lite Strategy, Inc. cotiza a 1.22 USD y tiene una capitalización bursátil de $37M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, …
| Periodo | 2026-11 | 2024-09 | 2024-05 | 2024-02 |
|---|---|---|---|---|
| Real | — | $-1.13 | $-1.37 | $-1.66 |
| Estimado | — | $-1.40 | $-1.26 | $-1.27 |
| Sorpresa | — | +19.3% | -8.7% | -30.7% |
| Métrica | LITS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -24935.2% | -38.6% | -24896.6% |
| Net Margin | -26647.9% | -33.6% | -26614.4% |
| FCF Margin | — | -13.9% | — |
| ROE | -170.9% | -40.4% | -130.5% |
| ROA | -166.7% | -32.0% | -134.7% |
| Current Ratio | 5.74 | 2.84 | +2.90 |
| Debt / Equity | — | 0.28 | — |